TRANSDERMAL FORMULATIONS CONTAINING HEPATITIS C VIRUS IMMUNOGENS AND AN ETHOXYLATED OIL

摘要

Embodiments of the present invention relate to the discovery of several formulations of a transdermal delivery composition that delivers low and high molecular weight compounds, preferably hepatitis C virus (HCV) antigens and immunogens to a subject. Aspects of the invention include said transdermal delivery compositions, transdermal delivery devices for. providing said compositions to subjects in need thereof and methods of making and using the foregoing.. Preferably, the HCV antigen is NS3/4A. The immunogenic composition can further comprise ribavirin as an adjuvant.